We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.50 | 34.00 | 35.00 | 34.50 | 34.50 | 34.50 | 33,661 | 07:34:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.62 | 124.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/4/2024 10:08 | bloomberg2 Apology accepted.Thank you and I fully agree we can move on and concentrate on CREO. | vasilis | |
18/4/2024 09:45 | Yes I sincerely apologise for any offence my extreme post and misspelling of your name !! Has coursed !! Can we please hold hands together and initiate a complete truce in hostilities! And focus on Creo medical making huge strides in Robotics in the NHS !! Who ever take the keys to number 10 | bloomberg2 | |
18/4/2024 09:21 | You started the political pivot !!Not me buddy | bloomberg2 | |
18/4/2024 08:12 | Typical Left wing Delusional response!! | bloomberg2 | |
17/4/2024 17:23 | Sorry Valsillis .... you're thinking on labour in power!! Is Delusional !! | bloomberg2 | |
17/4/2024 16:56 | Thanks for posting that link B2. I think it's a bit rich (no pun intended!) for Sunak to suddenly promote such developments in the NHS when the Tories have underfunded the NHS for years taking inflation into account. 'Dead Man Walking's' pronouncement is not surprising as Labour ratchet up the political noise around the NHS - especially investment in new technology including robotic surgery - as we get nearer to 'hanging time' for the Tories. It really should be a very nice situation for CREO to be in over the next 5 years as Labour especially are committed to such long overdue developments in the NHS. | vasilis | |
17/4/2024 14:05 | https://x.com/rckhll | bloomberg2 | |
17/4/2024 12:35 | Robotic surgery get the nod for further investment in the NHS !! Sunak says At Q&A Westminster | bloomberg2 | |
12/4/2024 16:32 | Drop without much volume and getting close to year results, MMs looking for cheap shares before update. | nimbo10 | |
12/4/2024 16:14 | Crazy price drop !! Unless something sinister in the background!! Technology cutting edge !! Sorry couldn't resist that one | bloomberg2 | |
10/4/2024 23:29 | It will be a NICE surprise when the rns drops that's for sure. | master investor | |
10/4/2024 22:15 | Funding is indeed not an issue in this case. Not sure if a sale is nailed on though. I think holders are going to be in for a nice surprise this year. | pacsltd | |
10/4/2024 21:21 | That is incorrect. You need to do more research. Funding is not an issue, and a sale is nailed on in the next 12-18 months | master investor | |
10/4/2024 19:21 | There is a logical fit with Intuitive which is a key reason I hold a few, but I would prefer them to get into bed as a bolt on the than be taken out. Unfortunately I think they didn't raise enough last time so unless a deal like that is done they will be coming around cap in hand inside the year. | peterrr3 | |
08/4/2024 16:08 | Hope so !! | bloomberg2 | |
08/4/2024 15:47 | Yeah great volume and increase , this particular share has a great future ahead . | up to the moon and back | |
08/4/2024 09:02 | Nice start | bloomberg2 | |
04/4/2024 10:47 | GDR got a NICE recommendation but 12 months from draft guidance. We're still "awaiting development" Since May 2023 NICE recommended in the May 2023 draft guidance. Following a public consultation of this draft guidance, which ends on 26 April 2024, final recommendations are expected to be published by NICE on 10 July 2024. recommended in draft guidance that the Genedrive® CYP2C19-ID test should be used as the point-of-care ("POC") test of choice before clopidogrel administration in the management of Ischemic Stroke ("IS") and Transient Ischaemic Attack ("TIA") patients. | hatfullofsky | |
03/4/2024 20:17 | But perky today.. | edwardt | |
29/3/2024 11:47 | One investor implies they will be taken out by intuitive | dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions